de Lemos JA - Search Results

1

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA. Das SR, et al. Among authors: de lemos ja. Circulation. 2005 Oct 4;112(14):2163-8. doi: 10.1161/CIRCULATIONAHA.105.555573. Circulation. 2005. PMID: 16203929

2

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Sabatine MS, et al. Among authors: de lemos ja. Circulation. 2002 Apr 16;105(15):1760-3. doi: 10.1161/01.cir.0000015464.18023.0a. Circulation. 2002. PMID: 11956114

3

Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application?

de Lemos JA, Morrow DA. de Lemos JA, et al. Circulation. 2002 Dec 3;106(23):2868-70. doi: 10.1161/01.cir.0000042763.07757.c0. Circulation. 2002. PMID: 12460861 No abstract available.

4

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.

de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. de Lemos JA, et al. Circulation. 2003 Feb 11;107(5):690-5. doi: 10.1161/01.cir.0000049742.68848.99. Circulation. 2003. PMID: 12578870 Clinical Trial.

5

B-type natriuretic peptide in ischemic heart disease.

Deo R, de Lemos JA. Deo R, et al. Among authors: de lemos ja. Curr Cardiol Rep. 2003 Jul;5(4):271-7. doi: 10.1007/s11886-003-0062-8. Curr Cardiol Rep. 2003. PMID: 12801444 Review.

6

B-type natriuretic peptide in cardiovascular disease.

de Lemos JA, McGuire DK, Drazner MH. de Lemos JA, et al. Lancet. 2003 Jul 26;362(9380):316-22. doi: 10.1016/S0140-6736(03)13976-1. Lancet. 2003. PMID: 12892964

7

Soluble CD40L: risk prediction after acute coronary syndromes.

Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U. Varo N, et al. Among authors: de lemos ja. Circulation. 2003 Sep 2;108(9):1049-52. doi: 10.1161/01.CIR.0000088521.04017.13. Epub 2003 Aug 11. Circulation. 2003. PMID: 12912804

8

Nesiritide in acute heart failure.

Drazner M, McGuire DK, de Lemos JA. Drazner M, et al. Among authors: de lemos ja. Lancet. 2003 Sep 20;362(9388):998-9. doi: 10.1016/S0140-6736(03)14380-2. Lancet. 2003. PMID: 14511940 No abstract available.

9

Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.

de Lemos JA, Morrow DA. de Lemos JA, et al. Rev Cardiovasc Med. 2003;4 Suppl 4:S37-46. Rev Cardiovasc Med. 2003. PMID: 14564227 Review.

10

Natriuretic peptide hormone measurement in acute coronary syndromes.

Maewal P, de Lemos JA. Maewal P, et al. Among authors: de lemos ja. Heart Fail Rev. 2003 Oct;8(4):365-8. doi: 10.1023/a:1026103601075. Heart Fail Rev. 2003. PMID: 14574059 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

586 results

Search Page